Pfizer is pushing India’s government for an “expedited approval pathway” for its COVID-19 vaccine — and announced a donation of medicines worth more than $70 million amid a catastrophic surge in infections in the country.
“Unfortunately, our vaccine is not registered in India although our application was submitted months ago,” CEO Albert Bourla wrote a letter to his colleagues in India, which he shared on LinkedIn Monday. “We are currently discussing with the Indian government an expedited approval pathway to make our Pfizer-BioNTech vaccine available for use in the country.”
He also said that Pfizer employees in the US, Europe and Asia are working to ship medications that India’s government has approved as part of its COVID treatment protocol.
People line up to get the COVID-19 vaccine outside a school-turned-vaccination centre in New Delhi on May 3, 2021.JEWEL SAMAD/AFP via Getty Images
“These medicines, valued at more than $70 million, will be made available immediately, and we will work